Posts tagged in vivo
Special issue of Risk Analysis Journal Explores Alternate Testing Strategies for Nanomaterials
Special issue of Risk Analysis Journal Explores Alternate Testing Strategies for Nanomaterials

Several themes were explored by The Emerging Nanoscale Materials Specialty Group (ENMSG) of the Society for Risk Analysis (SRA) co-organized by Jo Anne Shatkin and Kimberly Ong with a wonderful team of collaborators in a 2014 workshop on the use of alternate testing strategies (ATS) for risk assessment of nanomaterials.

Read More
Alternate Testing, Guidance, Nanomaterials, NanoEHS News, Risk AnalysisJames EdeSRA, Vireo Advisors, Alternative Testing Strategy, Risk Analysis, The Emerging Nanoscale Materials Specialty Group (ENMSG), Jo Anne Shatkin, Kimberly Ong, ATS, Nanomaterials, human health risks, oecd, Working Party on Manufactured Nanomaterials, WPMN, ECA, in vivo, in vitroComment
PETA Workshop Furthers Work on Developing Alternate Testing Strategies for Studying the Effects of Nanomaterials in the Lung

A workshop organized by People for the Ethical Treatment of Animals (PETA) Science Consortium Ltd. has led to several publications developing alternate testing strategies (non-animal methods) for studying nanomaterial effects in the lung.

Read More
Alternate Testing, NanomaterialsJames EdePETA, Archives of Toxicology, ATS, Alternative Testing Strategy, Nanomaterials, in vivo, pulmonary fibrosis, in vitro, non-animal testing, Safety, Carbon NanotubesComment